2.
Characteristics of screening services provided in NCCSP by level of medical institutions
| Variables | County/District-level | χ2 | P | Township level | χ2 | P | ||||||||
| Urban (n=10) | Rural (n=10) | Urban (n=165) | Rural (n=175) | |||||||||||
| Number | % | Number | % | Number | % | Number | % | |||||||
| NCCSP, National Cervical Cancer Screening Program; VIA/VILI, visual inspection with acetic acid and Lugol’s iodine; TBS, the bethesda system; HPV, human papillomavirus. | ||||||||||||||
| Organizing/enrollment | 6 | 60.0 | 10 | 100 | − | 0.087 | 138 | 83.6 | 164 | 93.7 | 8.689 | 0.003 | ||
| Gynecological examination | 10 | 100 | 10 | 100 | − | − | 106 | 64.2 | 98 | 56.0 | 2.404 | 0.121 | ||
| VIA/VILI examination | 3 | 30.0 | 8 | 80.0 | − | 0.070 | 26 | 15.8 | 33 | 18.9 | 0.569 | 0.451 | ||
| Colposcopy examination | 10 | 100 | 10 | 100 | − | − | 0 | 0 | 1 | 0.60 | − | − | ||
| Cytology testing | ||||||||||||||
| Liquid-based/Thinprep cytologic test | 5 | 50.0 | 2 | 20.0 | − | 0.350 | 0 | 0 | 0 | 0 | − | − | ||
| Pap smear test | 2 | 20.0 | 1 | 10.0 | − | 1.000 | 0 | 0 | 0 | 0 | − | − | ||
| TBS diagnosis | 3 | 30.0 | 7 | 70.0 | − | 0.179 | 0 | 0 | 0 | 0 | − | − | ||
| HPV testing | 9 | 90.0 | 7 | 70.0 | − | 0.582 | 0 | 0 | 0 | 0 | − | − | ||
| With genotyping | 7 | 70.0 | 0 | 0 | − | 0.003 | 0 | 0 | 0 | 0 | − | − | ||
| Without genotyping | 2 | 20.0 | 7 | 70.0 | − | 0.07 | 0 | 0 | 0 | 0 | − | − | ||
| Pathology diagnosis | 8 | 80.0 | 4 | 40.0 | − | 0.170 | 0 | 0 | 0 | 0 | − | − | ||
| Supervision and quality control | 7 | 70.0 | 7 | 70.0 | − | 1.000 | 0 | 0 | 0 | 0 | − | − | ||
| Training | 6 | 60.0 | 7 | 70.0 | − | 1.000 | 0 | 0 | 0 | 0 | − | − | ||
| Follow-up on abnormal/suspected cases | 9 | 90.0 | 9 | 90.0 | − | 1.000 | 95 | 57.6 | 112 | 64.0 | 1.472 | 0.225 | ||